Comment by weezin

dodobirdlord's explanation is solid. Basically your link describes "generic" versions of a drug (aka a "brand" drug) with an expired patent. For new drugs they don't have competition like a normal market does because of these patents. To give a summary of the section of the course I linked the market forces for "brand" drugs is the willingness for payers (insurance companies/ governments) to pay.